VVOS
Vivos Therapeutics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$8.48M
P/E Ratio
—
EPS
$-2.14
Beta
6.21
52W High
$7.95
52W Low
$0.55
50-Day MA
$0.99
200-Day MA
$2.21
Dividend Yield
—
Profit Margin
-121.40%
Forward P/E
—
PEG Ratio
—
About Vivos Therapeutics Inc
Vivos Therapeutics, Inc., a medical technology company, is dedicated to developing and commercializing treatment alternatives for patients with sleep-disordered breathing, such as mild to moderate obstructive sleep apnea (OSA). The company is headquartered in Highlands Ranch, Colorado.
Fundamentals
| Revenue (TTM) | $17.44M |
| Gross Profit (TTM) | $10.54M |
| EBITDA | $-18.59M |
| Operating Margin | -166.90% |
| Return on Equity | -663.00% |
| Return on Assets | -61.50% |
| Revenue/Share (TTM) | $1.70 |
| Book Value | $0.31 |
| Price-to-Book | 6.86 |
| Price-to-Sales (TTM) | 0.49 |
| EV/Revenue | 0.964 |
| EV/EBITDA | -0.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 3.40% |
| Shares Outstanding | $13.89M |
| Float | $11.67M |
| % Insiders | 26.06% |
| % Institutions | 14.25% |
Historical Volatility
HV 10-Day
69.53%
HV 20-Day
69.72%
HV 30-Day
121.84%
HV 60-Day
98.16%
HV Rank
86.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($2.42 target)
2
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026